Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism
Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.114.218560
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2015
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)